UK Research and Innovation (UKRI) have so far invested £44m into 78 interdisciplinary research projects into Antimicrobial Research (AMR) and with a new 20 year vision and 5 year action plan things are only set to increase.
With bacteria’s resistance to antibiotics increasingly spreading from one country to the next, antimicrobial resistance is now recognised as one of the most serious threats to human health this century. If things continue unchecked a 2014 AMR review paper estimates that by 2050 the cost of AMR could be up to $100 trillion and account for an additional 10 million extra deaths each year.
In response to this the UK’s Health Secretary, Matt Hancock, has announced a 20 year vision and 5 year action plan (2019 – 2024) with the intent to contain, control and mitigate antimicrobial resistance.
UKRI have committed £41m to support projects in partnership with members of the Joint Programme Initiative in AMR. To successfully deliver this research agenda the partnership will:
- Support co-ordinated AMR related research areas.
- Continue to influence global research strategies on AMR, ensuring alignment of UK-funded research, and emphasising the need for research to be useful for front-line teams.
- Develop interdisciplinary networks and inform and develop interventions across all sectors.
- Continue to develop the scientific capacity needed to support and deliver ongoing high-quality research in infectious disease, prevention and microbiology-related disciplines.
Both Matt Hancock and Theresa May have echoed the importance of this research and that it is pivotal it be conducted in a multidisciplinary and internal manor.
This is a summary of an article on which appeared on the MRC website. For the full article please click here.